INVASIVE BREAST CANCER
Clinical trials for INVASIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new INVASIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for INVASIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New MRI-Guided radiation approach tested for cancer treatment
Disease control Recruiting nowThis study is testing whether a new type of radiation therapy guided by MRI is safe and works well for people with gastric, breast, or other cancers. About 70 adults will receive this treatment along with chemotherapy. The goal is to see if the MRI guidance helps doctors target t…
Matched conditions: INVASIVE BREAST CANCER
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated May 17, 2026 09:24 UTC
-
New drug combo aims to wipe out HER2 low breast cancer before surgery
Disease control Recruiting nowThis study tests a drug called trastuzumab deruxtecan, which delivers chemotherapy directly to cancer cells with low levels of HER2, either alone or with anastrozole (a hormone blocker). The goal is to see if these treatments can eliminate all signs of cancer before surgery in pe…
Matched conditions: INVASIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated May 17, 2026 09:18 UTC
-
New approach may let breast cancer patients get reconstruction right away
Disease control Recruiting nowThis study is for people with advanced breast cancer (T3 or T4) who responded well to chemotherapy. Instead of the usual approach—mastectomy, then radiation, then delayed reconstruction—researchers are testing if giving radiation before surgery allows for immediate reconstruction…
Matched conditions: INVASIVE BREAST CANCER
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Vitamin d boost may improve breast cancer treatment response
Disease control Recruiting nowThis study looks at whether taking vitamin D supplements during standard chemotherapy can help shrink tumors more effectively in people with triple negative breast cancer who are low in vitamin D. About 50 participants will either receive vitamin D plus chemotherapy or just chemo…
Matched conditions: INVASIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New pill-and-shot combo aims to stop breast cancer growth before surgery
Disease control Recruiting nowThis study tests a daily pill called (Z)-endoxifen, sometimes combined with a monthly shot (goserelin) that temporarily stops the ovaries from making estrogen. The goal is to see if this treatment can slow or stop the growth of estrogen-receptor-positive, HER2-negative breast can…
Matched conditions: INVASIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Atossa Therapeutics, Inc. • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Promising drug combo targets aggressive inflammatory breast cancer
Disease control Recruiting nowThis study tests whether two drugs, trastuzumab deruxtecan and durvalumab, can safely shrink or eliminate tumors in people with stage III inflammatory breast cancer that has a protein called HER2. About 63 participants will receive the drugs before surgery. The main goal is to se…
Matched conditions: INVASIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Filipa Lynce, MD • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
New drug shows promise in shrinking aggressive breast cancer before surgery
Disease control Recruiting nowThis study tests a drug called sacituzumab govitecan, given before surgery, in people with localized triple-negative breast cancer. The goal is to see if it can eliminate all cancer in the breast and lymph nodes. Some participants may also receive pembrolizumab. The study involve…
Matched conditions: INVASIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
Cherry juice may shield cancer patients from chemo nerve pain
Prevention Recruiting nowThis study tests whether drinking tart cherry juice can help prevent nerve damage (neuropathy) caused by the chemotherapy drug paclitaxel in people with breast or ovarian cancer. About 86 participants will be randomly assigned to take either a high or low dose of the juice daily …
Matched conditions: INVASIVE BREAST CANCER
Phase: PHASE2 • Sponsor: University of California, Davis • Aim: Prevention
Last updated May 17, 2026 09:23 UTC
-
Whole-Body MRI aims to catch breast cancer return early
Knowledge-focused Recruiting nowThis study is testing whether a type of whole-body MRI (called DWB-MRI) can spot breast cancer that has come back or spread to other parts of the body earlier than standard scans. The goal is to see if finding it early leads to better treatment and longer survival. The study invo…
Matched conditions: INVASIVE BREAST CANCER
Phase: NA • Sponsor: European Institute of Oncology • Aim: Knowledge-focused
Last updated May 17, 2026 09:13 UTC
-
Lab-Grown mini tumors could predict chemo success in breast cancer
Knowledge-focused Recruiting nowThis study takes small tumor samples from 240 women with invasive breast cancer who are about to receive chemotherapy before surgery. Researchers will grow these samples into mini-tumors (organoids) in the lab to study each cancer's unique features. The goal is to see if these or…
Matched conditions: INVASIVE BREAST CANCER
Sponsor: Istituti Clinici Scientifici Maugeri SpA • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC
-
Scientists seek breast cancer clues from patient samples
Knowledge-focused Recruiting nowThis study collects leftover tissue from standard breast cancer surgeries and a one-time blood sample from 200 adults with breast cancer or precancer. Researchers will analyze these samples to identify tumor markers and gene patterns. The goal is to learn more about breast cancer…
Matched conditions: INVASIVE BREAST CANCER
Sponsor: Thomas Jefferson University • Aim: Knowledge-focused
Last updated May 11, 2026 20:41 UTC